A Study of Bitopertin (RO4917838) in Healthy Male Volunteers
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This randomized, double-blind, placebo-controlled, dose-escalating study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of bitopertin in healthy male volunteers. Subjects will be randomized in cohorts to receive single oral doses of either bitopertin or placebo.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 60 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Male healthy volunteer, 18 to 60 years of age inclusive
Body mass index (BMI) 19-35 kg/m2 inclusive
Supine blood pressure within the normal range of the center and heart rate >/= 40 provided QTcB is <450 ms
Subjects must agree to use a barrier method of contraception (e.g. condom) for the duration of the study and for 30 days after study completion
History or evidence of any clinically significant disease or disorder
Clinically significant ECG abnormalities
Positive for hepatitis B, hepatitis C or HIV infection
Previous treatment with iron for iron deficiency anemia
Regular smoker (>10 cigarettes, >3 pipefuls or >3 cigars per day)
History of alcohol and/or drug abuse or addiction within the last 2 years before study start
Any confirmed significant allergic reactions against any drug, or multiple allergies in the judgment of the investigator
Participation in a clinical study with an investigational drug within the last three months prior to screening
Any condition or disease detected during the medical interview/physical examination that would render the subject unsuitable for the study, place the subject at undue risk or interfere with the ability of the subject to complete the study in the opinion of the investigators or their designee